Home › NDC Lookup › RxCUI directory › RxCUI 2675280

Budesonide 0.2 MG/ML Oral Suspension — RxCUI 2675280

RxNorm drug concept · Semantic clinical drug
RxCUI 2675280 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2675280
Official nameBudesonide 0.2 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbudesonide 2 MG per 10 ML Oral Suspension; budesonide 2 MG in 10 mL Oral Suspension
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)3,205 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Budesonide Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You might notice some improvement on the very first day, but don't give up if you don't feel a big difference right away. The full benefit from this spray usually builds up over ab...
  • How long does it take for budesonide nasal spray to actually work?
  • Children 6 and older can use budesonide nasal spray, but an adult should supervise use for kids ages 6 to under 12. The spray should not be used in children under 6. One thing to k...
  • Can my child use this spray, and is it safe for long-term use in kids?
📖 Read our full Budesonide Nasal Spray guide →

🕸️ Concept Web — How Budesonide 0.2 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Budesonide 0.2 MG/ML Oral Suspension RxCUI 2675280

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Budesonide 19831
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Eohilia 2675281
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Budesonide Oral Suspension 2675279
    • Budesonide Oral Liquid Product 2675278
    • Budesonide Oral Product 1151338
    • Budesonide Oral Suspension [Eohilia] 2675285
    • Eohilia Oral Liquid Product 2675284
    • Eohilia Oral Product 2675283
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Budesonide 0.2 MG/ML SCDC · 2675277
  • Budesonide Oral Suspension SCDF · 2675279
  • Budesonide Oral Liquid Product SCDG · 2675278
  • Budesonide Oral Product SCDG · 1151338

Brand-Name Concepts

  • Budesonide 0.2 MG/ML Oral Suspension [Eohilia] SBD · 2675286
  • Budesonide 0.2 MG/ML [Eohilia] SBDC · 2675282
  • Budesonide Oral Suspension [Eohilia] SBDF · 2675285
  • Eohilia Oral Liquid Product SBDG · 2675284
  • Eohilia Oral Product SBDG · 2675283
  • Eohilia BN · 2675281

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2675280 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64764-0105-00 10 POUCH in 1 CARTON (64764-105-00) / 10 mL in 1 POUCH (647... Eohilia TAKEDA PHARMACEUTICALS AMERICA, INC. 2024-02-09
64764-0105-60 60 POUCH in 1 CARTON (64764-105-60) / 10 mL in 1 POUCH (647... Eohilia TAKEDA PHARMACEUTICALS AMERICA, INC. 2024-02-09
Observed labelers: TAKEDA PHARMACEUTICALS AMERICA, INC. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$3.2229
Range $3.2229–$3.2229 · middle 50% $3.2229–$3.2229 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.